
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.580 | 100.580 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.451 | 19.680 |
Price to Book | 2.522 | 3.883 |
Price to Sales | 2.521 | 2.233 |
Price to Cash Flow | 14.715 | 14.780 |
Dividend Yield | 0.419 | 1.493 |
5 Years Earnings Growth | 9.794 | 9.837 |
Number of long holdings: 32
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Swedish Orphan Biovitrum | SE0000872095 | 8.81 | 290.60 | 0.00% | |
UCB | BE0003739530 | 8.63 | 200.70 | +1.72% | |
Argen-X | NL0010832176 | 5.25 | 598.40 | +5.80% | |
Fresenius SE | DE0005785604 | 4.94 | 47.470 | -0.46% | |
Zealand Pharma | DK0060257814 | 4.53 | 423.70 | +1.70% | |
Asker Healthcare AB | SE0024171458 | 4.06 | 103.24 | +2.10% | |
Innovent Biologics | KYG4818G1010 | 4.06 | 99.95 | +0.50% | |
H Lundbeck B | DK0061804770 | 3.67 | 39.04 | -2.11% | |
Uniphar | IE00BJ5FQX74 | 3.56 | 4.04 | +3.06% | |
Sandoz | CH1243598427 | 3.26 | 50.60 | +0.76% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund I | 8.16B | 25.79 | 28.69 | 20.30 | ||
Global Technology Fund R | 8.16B | 25.42 | 28.04 | 19.78 | ||
Global Technology Fund | 8.16B | 17.39 | 29.43 | 19.08 | ||
IE00BFMFD979 | 3.44B | 7.08 | -5.04 | - | ||
IE00BJ205H20 | 3.44B | 6.77 | -5.27 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review